Clinical Trial Update: Sulforaphane for the Treatment of Young Men With Autism Spectrum Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating sulforaphane for treating autism spectrum disorders in young men; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Autistic Disorder

Drugs mentioned

• Sulforaphane (sulforaphane)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Autism Spectrum Disorder, Autistic Disorder | Phase 2 | Status: COMPLETED | Results posted: 2020-05-15